|Webcasts|November 12, 2019
Trends and Insights for Your Oncology Trial: Considerations for biotech companies embarking on oncology clinical trials
Author(s)IQVIA Biotech
This complimentary webinar explores top trends influencing oncology clinical development. We will share insights and best practices to help ensure your future oncology trials are designed to be quick and efficient and yield high quality data for the best chance for success. Live: Tuesday, November 12, 2019 at 10am EST On demand available after airing until Nov. 12, 2020. Register free
Advertisement
Register free: http://www.appliedclinicaltrialsonline.com/act_w/insights
Event Overview:
A record number of new oncology drugs have been approved in recent years, bringing new treatment options to patients. However, despite robust levels of pipeline activity, oncology trials are complex and remain a challenging area for research and development.
Join this webinar to learn about trends shaping the development and delivery of cancer treatment worldwide. We will share insights and best practices to help ensure your future oncology trials are designed to be quick and efficient and yield high-quality data for the best chance of success. Our experts will address specific considerations for biotech companies embarking on oncology trials.
Key Learning Objectives:
Understand top trends driving change in oncology clinical development today and through 2023.
Recognize the impact of new therapies and care standards on trial planning and design.
Learn how to apply real world evidence to trial design, trial start-up, and trial conduct for more efficient and effective trials.
Speakers: Murray Aitken, Executive Director, IQVIA Institute for Human Data Science
Andrew Zupnick, Ph.D., Vice President, Oncology Strategy, IQVIA Biotech
Time and date: Tuesday, November 12, 2019 at 10am EST
On demand available after airing until Nov. 12, 2020.
Sponsor: IQVIA
Register free: http://www.appliedclinicaltrialsonline.com/act_w/insights
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- The Impact of ICH E6(R3) on Biospecimen Management
June 25th 2025
- The Top 5 Myths About eCOAs In 2025
March 25th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Investigational PD-L1 x VEGF-A Bispecific Antibody Demonstrates Strong Overall Response Rate in Phase II Small Cell Lung Cancer Trial
2
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
3
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
4
How Recent Policy Changes Could Impact Clinical Research
5